, Volume 47, Issue 1, pp 125–128 | Cite as

Severe pulmonary haemorrhage syndrome in leptospirosis in a returning traveller

  • Andreas SchönfeldEmail author
  • B. Jensen
  • H. M. Orth
  • D. Tappe
  • T. Feldt
  • D. Häussinger
Case Report


Clinical presentation of leptospirosis ranges from asymptomatic infection to fulminant, life-threatening disease. Pulmonary involvement in terms of severe pulmonary haemorrhage syndrome (SPHS) has recently become a more frequently reported facet of leptospirosis and correlates with high mortality rates. It has not yet been described in returning German travellers. We present a case of a healthy young man developing massive pulmonary haemorrhage and severe ARDS requiring mechanical ventilation and high-dose catecholamines after travelling to Indonesia. Leptospirosis was verified by blood PCR as well as serology and treated with high-dose, intravenous penicillin. Outcome was favourable, the patient recovered completely. Leptospirosis and SPHS should be taken into account as an emerging infectious disease in patients with fever and lung involvement.


Leptospirosis Severe pulmonary haemorrhage syndrome Travel medicine Emerging infectious disease 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Sehgal S, Murhekar M, Sugunan A. Outbreak of leptospirosis with pulmonary involvement in north Andaman. Indian J Med Res. 1995;102:9–12.Google Scholar
  2. 2.
    Trevejo RT, Rigau-Pérez JG, Ashford DA, McClure EM, Jarquín-González C, Amador JJ, et al. Epidemic leptospirosis associated with pulmonary hemorrhage—Nicaragua, 1995. J Infect Dis. 1998;178:1457–63.CrossRefGoogle Scholar
  3. 3.
    Gouveia EL, Metcalfe J, De Carvalho ALF, Aires TS, Villasboas-Bisneto JC, Queirroz A, et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis. 2008;14:505.CrossRefGoogle Scholar
  4. 4.
    Brehm TT, Schulze Zur Wiesch J, Lutgehetmann M, Tappe D, Eisermann P, Lohse AW, et al. Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center. Infection. 2018. Scholar
  5. 5.
    Weil A. Peculiar acute infection with splenic enlargement, jaundice and nephritis. Dtsch Arch Klin Med. 1886;39:209.Google Scholar
  6. 6.
    Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17:494–501. Scholar
  7. 7.
    Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9:e0003898.CrossRefGoogle Scholar
  8. 8.
    Brockmann S, Piechotowski I, Bock-Hensley O, Winter C, Oehme R, Zimmermann S, et al. Outbreak of leptospirosis among triathlon participants in Germany, 2006. BMC Infect Dis. 2010;10:91.CrossRefGoogle Scholar
  9. 9.
    Moeschlin S. Lungeninfiltrate beim Ikterus infectiosus Weil. Schwabe, Basel 1943.Google Scholar
  10. 10.
    Carvalho CRR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med. 2002;23:469–78.CrossRefGoogle Scholar
  11. 11.
    Silva JJPD, Dalston MO, Carvalho JEMD, Setúbal S, Oliveira JMCD, Pereira MM. Clinicopathological and immunohistochemical featuresof the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop. 2002;35:395–9.CrossRefGoogle Scholar
  12. 12.
    Vieira SR, Brauner JS. Leptospirosis as a cause of acute respiratory failure: clinical features and outcome in 35 critical care patients. Braz J Infect Dis. 2002;6:135–9.CrossRefGoogle Scholar
  13. 13.
    Spichler AS, Vilaça PJ, Athanazio DA, Albuquerque JO, Buzzar M, Castro B, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008;79:911–4.CrossRefGoogle Scholar
  14. 14.
    Budiono E, Sumardi B, Hisyam B, Hartopo AB. Pulmonary involvement predicts mortality in severe leptospirosis patients. Acta Med Indones. 2009;41:11–4.Google Scholar
  15. 15.
    Liao C-Y, Ben R-J, Wu H-M, Chang S-K, Liu M-Y, Chin H-K, et al. Acute respiratory distress syndrome manifested by leptospirosis successfully teated by extracorporeal membrane oxygenation (ECMO). Intern Med. 2015;54:2943–6.CrossRefGoogle Scholar
  16. 16.
    Cantwell T, Ferre A, Jan NVS, Blamey R, Dreyse J, Baeza C, et al. Leptospirosis-associated catastrophic respiratory failure supported by extracorporeal membrane oxygenation. J Artif Organs. 2017;20:1–6.CrossRefGoogle Scholar
  17. 17.
    Jayakrishnan B, Abid FB, Balkhair A, Alkaabi JK, Al-Rawas OA, George J, et al. Severe pulmonary involvement in leptospirosis: alternate antibiotics and systemic steroids. Sultan Qaboos Univ Med J. 2013;13:318.CrossRefGoogle Scholar
  18. 18.
    Kularatne SA, Budagoda BSS, de Alwis VKD, Wickramasinghe WS, Bandara JRP, Pathirage LMM, et al. High efficacy of bolus methylprednisolone in severe leptospirosis: a descriptive study in Sri Lanka. Postgrad Med J. 2011;87:13–7.CrossRefGoogle Scholar
  19. 19.
    Wani H. Ueber die prophylaxe der Spirochaetosis icterohaemorrhagica Inada (Weilschen Krankheit) durch schutzimpfung. Z Immun Exp Ther. 1933;79:1–26.Google Scholar
  20. 20.
    Benbrik E, Pouliquen P, Dômont A. Evaluation de la tolérance de la vaccination contre Leptospira icterohaemorrhagiae chez 50 employés de canaux. Arch Mal Prof Méd Travail. 2001;62:35–40.Google Scholar
  21. 21.
    Grassmann AA, Souza JD, McBride AJA. A universal vaccine against leptospirosis: are we going in the right direction? Front Immunol. 2017;8:256.Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University HospitalHeinrich Heine UniversityDüsseldorfGermany
  2. 2.Bernhard-Nocht-Institute of Tropical MedicineHamburgGermany

Personalised recommendations